A team of researchers is testing the hypothesis that a hormone called kisspeptin could replace the human chorionic gonadotropin hormone used in in vitro fertilization procedures. Kisspeptin is believed to be a gentler hormone that does not run the same risks as the potent hCG hormone, which can cause ovarian hyperstimulation syndrome. The team tested kisspeptin in 30 women undergoing the IVF procedure and the first healthy baby was born in April. Final results will be known in six months, said team leader Waljit Dhillo.

Full Story:
New Scientist

Related Summaries